A gas chromatographic-mass spectrometric (GC-MS) method for analysis of unconjugated steroids in a rat testis is described. A combined solvent-solid extraction procedure, utilizing Lipidex 1000 and Sep-Pak C 18, gives a 25-fold purified extract. Steroids in this extract are fractionated by straight phase high-performance liquid chromatography (HPLC) on a LiChrosorb DIOL column in n-hexane-2-propanol, 92:8 (v/v). Four fractions are collected and the steroids are converted to tert-butyldimethylsilyl (TBDMS), 3-enol-TBDMS, and mixed TBDMS-trimethylsilyl (TMS) derivatives using TBDMS- and TMS-imidazole with sodium formate as catalyst under conditions suitable for the steroids present in the respective fractions. The derivatives are purified by reversed phase HPLC in 100% methanol and are analyzed by GC-MS, using selected ion monitoring of the major ions of high mass. For quantification, a mixture of known amounts of ten 14C-labelled steroids, [ 3H]estradiol and [ 2H 3]estradiol are added to the testis homogenate. The mean concentrations (ng/g wet wt) of the twelve steroids determined were: 4-androstene-3,17-dione, 4.0; testosterone, 127; 17β-hydroxy-5α-androstan-3-one, 4.5; 5α-andro-stane-3α,17β-diol, 5.7; 5α-androstane-3β,17β-diol, 1.5; progesterone, 5.5; 17α-hydroxyprogesterone, 14.4; 3β-hydroxy-5-androsten-17-one, 0.07; 5-androstene-3β,17β-diol, 0.25; 3β-hydroxy-5-pregnen-20-one, 10.3; 3β,17β-dihydroxy-5-pregnen-20-one, 0.95; and estradiol, 0.025. Variations between animals were large whereas testes from the same animal in most cases had similar steroid concentrations.